Cormorant Asset Management LP 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:11 pm Purchase | 2024-09-30 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | Cormorant Asset Management LP | 2,940,921 8.040% | 638 (+0.02%) | Filing |
| 2024-06-20 4:01 pm Purchase | 2024-06-10 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | Cormorant Asset Management LP | 2,940,283 8.040% | 2,940,283 (New Position) | Filing |